Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models
Date
2012
Authors
Low, H.
Hoang, A.
Forbes, J.
Thomas, M.
Lyons, J.G.
Nestel, P.
Bach, L.
Sviridov, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Diabetologia, 2012; 55(9):2513-2521
Statement of Responsibility
Conference Name
Abstract
Aims/hypothesis: We investigated the contribution of AGEs to the impairment of reverse cholesterol transport (RCT) variables in diabetic individuals and in two animal models of diabetic obesity and of renal impairment.
Conclusions/interpretation: AGEs are unlikely to contribute significantly to the impairment of RCT in type 2 diabetes.
Methods: The capacity of plasma and HDL from 26 individuals with moderately controlled type 2 diabetes to support cholesterol efflux was compared with 26 age- and sexmatched individuals without diabetes. We also compared the rates of RCT in vivo in two animal models: db/db mice and mice with chronic renal failure.
Results: Diabetic individuals had characteristic dyslipidaemia and higher levels of plasma AGEs. The capacity of whole plasma, ApoB-depleted plasma and isolated HDL to support cholesterol efflux was greater for diabetic patients compared with controls despite their lower HDL-cholesterol levels. The capacity of plasma to support cholesterol efflux correlated with plasma levels of cholesteryl ester transfer protein and levels of ApoB, but not with levels of AGE. RCT was severely impaired in db/db mice despite elevated HDL-cholesterol levels and no change in AGE concentration, whereas RCT in uraemic mice was unaffected despite elevated AGE levels.
School/Discipline
Dissertation Note
Provenance
Description
Data source: Supplementary material, https://doi.org/10.1007/s00125-012-2570-9
Link to a related website: https://link.springer.com/content/pdf/10.1007%2Fs00125-012-2570-9.pdf, Open Access via Unpaywall
Access Status
Rights
Copyright 2012 Springer-Verlag